Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Cardiology
    • End of Life
    • Gastroentrology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Nephrology
    • Neurology
    • Oncology
    • Ophthalmology
    • Opioids
    • Rare Diseases
    • Respiratory
    • Women’s Health
  • RESOURCES
  • CONTACT

Understanding IDA in a Women’s Health Context: The Prevalence, Pathophysiology, Presentation, and Impact on Clinical Endpoints and Patient-reported Outcomes

  • Post author By salmocc
  • Post date August 23, 2023

Understanding IDA in a Women’s Health Context: The Prevalence, Pathophysiology, Presentation, and Impact on Clinical Endpoints and Patient-reported Outcomes

 Women's Health

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses

American Academy of CME, Inc., designates this educational activity for 0.5 ANCC contact hours (0.1 pharmacotherapeutic contact hours).

Pharmacists

This activity provides 0.5 ACPE contact hours (.05 CEUs) of continuing education credit. Universal Activity Number: UAN JA4008191-9999-23-025-H04-P.

  • Listing ID: 2495

← Cornerstones Best of DDW in Inflammatory Bowel Disease 2023 Webcast → Pillars of Change: An Expert Appraisal of Evidence-driven Approaches for Diagnosing, Evaluating, and Treating IDA in the OB/GYN Clinic